Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS
· Delayed Price · Currency is USD
0.1178
0.00 (0.00%)
Apr 22, 2025, 4:00 PM EDT
Nymox Pharmaceutical Market Cap
Nymox Pharmaceutical has a market cap or net worth of $11.14 million as of April 23, 2025. Its market cap has decreased by -73.17% in one year.
Market Cap
11.14M
Enterprise Value
13.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.12
Market Cap Chart
Since November 26, 1997, Nymox Pharmaceutical's market cap has decreased from 118.04M to 11.14M, a decrease of -90.56%. That is a compound annual growth rate of -8.25%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.74B |
| Endo Inc. | 1.64B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 704.15M |
| Elite Pharmaceuticals | 436.82M |
| Northwest Biotherapeutics | 402.62M |
| Glass House Brands | 384.26M |
| CytoDyn | 264.36M |